Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding.
暂无分享,去创建一个
[1] K. Jacobson,et al. Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism. , 1991, The Journal of pharmacology and experimental therapeutics.
[2] J. Phillis,et al. Adenosine and Adenine Nucleotides As Regulators of Cellular Function , 1991 .
[3] U. Ungerstedt,et al. Theophylline concentration in the extracellular space of the rat brain: measurement by microdialysis and relation to behaviour. , 1990, European journal of pharmacology.
[4] D J Greenblatt,et al. Caffeine‐induced behavioural stimulation is dose‐ and concentration‐dependent , 1990, British journal of pharmacology.
[5] S. Freedman,et al. Direct measurement of muscarinic agents in the central nervous system of mice using ex vivo binding. , 1989, European journal of pharmacology.
[6] P F Morgan,et al. Potent convulsant actions of the adenosine receptor antagonist, xanthine amine congener (XAC). , 1989, Life sciences.
[7] J. Daly,et al. 3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs. , 1988, Life sciences.
[8] L. Dykstra,et al. Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration. , 1987, The Journal of pharmacology and experimental therapeutics.
[9] R. Wurtman,et al. Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl)theophylline. , 1987, The Journal of pharmacology and experimental therapeutics.
[10] K. Jacobson,et al. [3H]xanthine amine congener of 1,3-dipropyl-8-phenylxanthine: an antagonist radioligand for adenosine receptors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[11] G. Lu,et al. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. , 1986, Molecular pharmacology.
[12] T. Nowak,et al. Nimodipine levels in gerbil brain following parenteral drug administration. , 1985, Journal of neurosurgery.
[13] K. Jacobson,et al. Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors. , 1985, Journal of medicinal chemistry.
[14] L. Heller,et al. Inhibition of rat ventricular automaticity by adenosine. , 1985, The American journal of physiology.
[15] J. Daly,et al. 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors. , 1985, Journal of medicinal chemistry.
[16] S. Snyder,et al. Adenosine receptors and the actions of methylxanthines , 1981, Trends in Neurosciences.
[17] S H Snyder,et al. Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines. , 1981, Life sciences.
[18] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.